{"entity":{"type":"insider","cik":"0001592481","url":"/insider/0001592481","json_url":"/insider/0001592481.json","name":"Salkind Gene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2019-09-19","last":"2025-11-21","span_basis":"filed_date"},"name_variants":[{"name":"Salkind Gene","source":"filing","n_filings":9,"first_seen":"2019-09-19","last_seen":"2025-11-21"}],"transactions":[{"id":5048696,"accession":"0001477932-25-008535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-25-008535","line_url":"/filing/0001477932-25-008535#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"UPEXI, INC.","issuer_ticker":"UPXI","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":218750.0,"shares_owned_after_display":"218,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":5012483,"accession":"0001477932-25-008466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001477932-25-008466","line_url":"/filing/0001477932-25-008466","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"UPEXI, INC.","issuer_ticker":"UPXI","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":2.73,"price_display":"2.73","price_state":"stated","total_value":546000.0,"total_display":"546,000.00","total_whole":"546,000","shares_owned_after":168750.0,"shares_owned_after_display":"168,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider","n_lines":2},{"id":4892872,"accession":"0001477932-25-005338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-25-005338","line_url":"/filing/0001477932-25-005338#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"UPEXI, INC.","issuer_ticker":"UPXI","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20243.0,"shares_display":"20,243","price_per_share":4.94,"price_display":"4.94","price_state":"stated","total_value":100000.42,"total_display":"100,000.42","total_whole":"100,000","shares_owned_after":385370.0,"shares_owned_after_display":"385,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-11","filed_date":"2025-07-30","scope":"insider"},{"id":5138196,"accession":"0001477932-25-002979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-25-002979","line_url":"/filing/0001477932-25-002979#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"UPEXI, INC.","issuer_ticker":"UPXI","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":241229.0,"shares_display":"241,229","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":550002.12,"total_display":"550,002.12","total_whole":"550,002","shares_owned_after":365127.0,"shares_owned_after_display":"365,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-17","filed_date":"2025-04-25","scope":"insider"},{"id":2124793,"accession":"0001683168-24-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-24-000161","line_url":"/filing/0001683168-24-000161#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"Coeptis Therapeutics Holdings, Inc.","issuer_ticker":"COEP","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11600.0,"shares_display":"11,600","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":8004.0,"total_display":"8,004.00","total_whole":"8,004","shares_owned_after":284056.0,"shares_owned_after_display":"284,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":7984052,"accession":"0001683168-23-006169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-23-006169","line_url":"/filing/0001683168-23-006169#line-2","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"Coeptis Therapeutics Holdings, Inc.","issuer_ticker":"COEP","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4006.0,"shares_display":"4,006","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":4046.06,"total_display":"4,046.06","total_whole":"4,046","shares_owned_after":4046.0,"shares_owned_after_display":"4,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-30","scope":"insider"},{"id":7984050,"accession":"0001683168-23-006169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-23-006169","line_url":"/filing/0001683168-23-006169#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"Coeptis Therapeutics Holdings, Inc.","issuer_ticker":"COEP","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28638.0,"shares_display":"28,638","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":26060.58,"total_display":"26,060.58","total_whole":"26,061","shares_owned_after":28638.0,"shares_owned_after_display":"28,638","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-08-30","scope":"insider"},{"id":6949743,"accession":"0001477932-22-001943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001477932-22-001943","line_url":"/filing/0001477932-22-001943#line-1","is_derivative":false,"issuer_cik":"0001592481","issuer_name":"GROVE, INC.","issuer_ticker":"GRVI","issuer_name_source":null,"issuer_url":"/issuer/0001592481","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":125000.0,"shares_owned_after_display":"125,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-04-01","scope":"insider"},{"id":9294664,"accession":"0001683168-20-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-20-000197","line_url":"/filing/0001683168-20-000197","is_derivative":false,"issuer_cik":"0001084267","issuer_name":"Mobiquity Technologies, Inc.","issuer_ticker":"MOBQ","issuer_name_source":null,"issuer_url":"/issuer/0001084267","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000000.0,"shares_display":"175,000,000","price_per_share":0.018255714285714285,"price_display":"0.02","price_state":"stated","total_value":3194750.0,"total_display":"3,194,750.00","total_whole":"3,194,750","shares_owned_after":126318355.0,"shares_owned_after_display":"126,318,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2020-01-21","scope":"insider","n_lines":3},{"id":7960233,"accession":"0001683168-19-002976","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-19-002976","line_url":"/filing/0001683168-19-002976","is_derivative":false,"issuer_cik":"0001084267","issuer_name":"Mobiquity Technologies, Inc.","issuer_ticker":"MOBQ","issuer_name_source":null,"issuer_url":"/issuer/0001084267","owner_cik":"0001592481","owner_name":"Salkind Gene","owner_display_name":"Salkind Gene","owner_url":"/insider/0001592481","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000000.0,"shares_display":"175,000,000","price_per_share":0.018255714285714285,"price_display":"0.02","price_state":"stated","total_value":3194750.0,"total_display":"3,194,750.00","total_whole":"3,194,750","shares_owned_after":253818355.0,"shares_owned_after_display":"253,818,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001775194","name":"UPEXI, INC.","url":"/issuer/0001775194","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2022-04-01","last_seen":"2025-11-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001759186","name":"Coeptis Therapeutics Holdings, Inc.","url":"/issuer/0001759186","role":"Director","n_filings":2,"first_seen":"2023-08-30","last_seen":"2024-01-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001084267","name":"Mobiquity Technologies, Inc.","url":"/issuer/0001084267","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2019-09-19","last_seen":"2020-01-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001592481","retrieved_at":"2026-08-27T17:03:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}